Target intelligence / Profile preview

Alginate biosynthesis protein Alg8 (Alg8)

Target
Alg8
Molecular classification
Enzyme, Glycosyltransferase, Membrane protein
01

Overview

Alginate biosynthesis protein Alg8 is an essential inner-membrane glycosyltransferase in Pseudomonas aeruginosa that serves as the catalytic subunit for alginate polymerization (MDPI, https://www.mdpi.com/2076-2607/11/12/2833; NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346658/). It utilizes GDP-mannurate as a substrate to synthesize long chains of polymannuronate, which are subsequently modified and secreted to form the alginate exopolysaccharide (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135710/). Alginate is a primary component of the biofilm matrix in mucoid P. aeruginosa strains, which are hallmark pathogens in the lungs of cystic fibrosis patients (Microbiology Society, https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.2007/016063-0). This protective matrix shields the bacteria from the host immune system and significantly increases resistance to antibiotic therapy (ACS, https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00018). Because Alg8 is a bottleneck in the alginate production pathway, it is considered a high-priority target for the development of anti-virulence drugs designed to disrupt biofilm formation and restore antibiotic efficacy (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346658/).

Other names
Alginate polymeraseGlycosyltransferase Alg8Poly(beta-D-mannuronate) synthaseAlg8 glycosyltransferase
02

Biological functions

Alginate biosynthesisBiofilm formationPolymannuronate polymerization
03

Disease associations

InfectionCystic fibrosisChronic obstructive pulmonary disease
04

Safety considerations

Potential cross-reactivity with human glycosyltransferasesTherapeutic challenge of targeting membrane-embedded enzymesDevelopment of bacterial resistance
05

Biomarkers

Alginate concentrationMucoid phenotype of Pseudomonas aeruginosa

Beyond the preview

Go deeper on Alginate biosynthesis protein Alg8 (Alg8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alginate biosynthesis protein Alg8 (Alg8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call